293 related articles for article (PubMed ID: 26705180)
21. Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.
Asano N; Suzuki R; Ohshima K; Kagami Y; Ishida F; Yoshino T; Ogawa H; Morishima Y; Nakamura S
Int J Hematol; 2010 Apr; 91(3):426-35. PubMed ID: 20217288
[TBL] [Abstract][Full Text] [Related]
22. Primary gastrointestinal anaplastic large cell lymphoma.
Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
[TBL] [Abstract][Full Text] [Related]
23. Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL.
Steinhilber J; Bonin M; Walter M; Fend F; Bonzheim I; Quintanilla-Martinez L
PLoS One; 2015; 10(2):e0117780. PubMed ID: 25688981
[TBL] [Abstract][Full Text] [Related]
24. Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas.
Iwamizu-Watanabe S; Yamashita Y; Yatabe Y; Nakamura S; Mori N
Pathol Int; 2004 Jul; 54(7):503-9. PubMed ID: 15189504
[TBL] [Abstract][Full Text] [Related]
25. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 expression in peripheral T-cell lymphomas.
Song JY; Song L; Herrera AF; Venkataraman G; Murata-Collins JL; Bedell VH; Chen YY; Kim YS; Tadros R; Nathwani BN; Weisenburger DD; Feldman AL
Mod Pathol; 2016 Nov; 29(11):1306-1312. PubMed ID: 27469326
[TBL] [Abstract][Full Text] [Related]
27. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
28. BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas.
Carbone A; Gloghini A; Gaidano G; Dalla-Favera R; Falini B
Blood; 1997 Sep; 90(6):2445-50. PubMed ID: 9310496
[TBL] [Abstract][Full Text] [Related]
29. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Xu H; Glicksman CA
Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
Damm-Welk C; Schieferstein J; Schwalm S; Reiter A; Woessmann W
Br J Haematol; 2007 Aug; 138(4):459-66. PubMed ID: 17608768
[TBL] [Abstract][Full Text] [Related]
31. ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesions.
Borisch B; Yerly S; Cerato Ch; Schwaller J; Wacker P; Ozsahin AH; Brousse N; Hoessli DC
Eur J Haematol; 2003 Oct; 71(4):243-9. PubMed ID: 12950232
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of ALK-positive anaplastic large cell lymphoma based on CD30 testing.
Gascoyne RD
Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 2):3-6. PubMed ID: 24852617
[No Abstract] [Full Text] [Related]
34. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
35. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic large cell lymphoma: the most common T-cell lymphoma in pakistan.
Syed S; Khalil S; Pervez S
Asian Pac J Cancer Prev; 2011; 12(3):685-9. PubMed ID: 21627364
[TBL] [Abstract][Full Text] [Related]
38. CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma.
Awaya N; Mori S; Takeuchi H; Mori S; Sugano Y; Kamata T; Takeuchi T; Abe T
Am J Hematol; 2002 Mar; 69(3):200-4. PubMed ID: 11891807
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
[TBL] [Abstract][Full Text] [Related]
40. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
McQuaid DC; Katz SG; Xu ML
Am J Clin Pathol; 2022 Aug; 158(2):173-176. PubMed ID: 35460405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
